Better Therapeutics Stock Price

-0.03 (-0.72%)
Volume 52,303
Bid Price 3.99
Ask Price 4.17
News -
Day High 4.18


52 Week Range


Day Low 3.9701
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Better Therapeutics Inc BTTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -0.72% 4.15 18:00:01
Open Price Low Price High Price Close Price Prev Close
4.18 3.9701 4.18 4.15 4.18
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
491 52,303 $ 4.09 $ 213,761 - 3.9701 - 29.40
Last Trade Time Type Quantity Stock Price Currency
16:36:59 1 $ 4.16 USD


Draw Mode:

Better Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 97.94M 23.60M 7.55M $ 15.00k $ - -0.47 -12.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 12.95M 1.70%

more financials information »

Better Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.804.953.97014.5492,192-0.65-13.54%
1 Month4.645.643.97015.01139,306-0.49-10.56%
3 Months10.0429.403.970114.682,574,932-5.89-58.67%
6 Months10.0429.403.970114.682,574,932-5.89-58.67%
1 Year10.0429.403.970114.682,574,932-5.89-58.67%
3 Years10.0429.403.970114.682,574,932-5.89-58.67%
5 Years10.0429.403.970114.682,574,932-5.89-58.67%

Better Therapeutics Description

Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

Your Recent History
Better The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.